GeneThera, Inc.
GTHR · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $5 | $5 | $5 | $5 |
| Gross Profit | -$5 | -$5 | -$5 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $180 |
| G&A Expenses | $1,009 | $741 | $739 | $3,927 |
| SG&A Expenses | $1,009 | $741 | $739 | $529 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$5 |
| Other Operating Expenses | $0 | $0 | $0 | $3,398 |
| Operating Expenses | $1,009 | $741 | $739 | $3,927 |
| Operating Income | -$1,009 | -$741 | -$739 | -$3,927 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$34 | $222 | $530 |
| Pre-Tax Income | -$1,011 | -$774 | -$518 | -$3,396 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,011 | -$774 | -$518 | -$4,045 |
| % Margin | – | – | – | – |
| EPS | -0.04 | -0.04 | -0.015 | -0.11 |
| % Growth | -0.5% | -161.8% | 86.2% | – |
| EPS Diluted | -0.04 | -0.04 | -0.015 | -0.11 |
| Weighted Avg Shares Out | 25,352 | 20,310 | 35,903 | 37,737 |
| Weighted Avg Shares Out Dil | 25,352 | 20,310 | 35,903 | 37,738 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $34 | $29 | $118 |
| Depreciation & Amortization | $5 | $5 | $5 | $5 |
| EBITDA | -$1,004 | -$735 | -$484 | -$3,273 |
| % Margin | – | – | – | – |